{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:17:50Z","timestamp":1769599070206,"version":"3.49.0"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,12]]},"DOI":"10.18632\/oncotarget.11401","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T16:27:24Z","timestamp":1471624044000},"page":"64984-64998","source":"Crossref","is-referenced-by-count":4,"title":["Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA\/JAK2\/Lyn\/Akt network complex in CEL"],"prefix":"10.18632","volume":"8","author":[{"given":"Bin","family":"Li","sequence":"first","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"},{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang Ya Hospital, Central South University, Changsha, People\u2019s Republic of China"},{"name":"Division of Oncology, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangsen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang Ya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijuan","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Hematology, Institute of Molecular Hematology, The Second Xiang Ya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchen","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Oncology, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengxi","family":"He","sequence":"additional","affiliation":[{"name":"Division of Oncology, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Oncology, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzi","family":"Peng","sequence":"additional","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeping","family":"Dong","sequence":"additional","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie Qiong","family":"Tan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genetics, Xiangya Medical School, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nacef","family":"Bahri","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"},{"name":"The Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences\/Shanghai Jiao Tong University School of Medicine, Shanghai, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojun","family":"Duan","sequence":"additional","affiliation":[{"name":"Medical Research Center, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"1","first-page":"1201","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"27","author":"Malone","year":"2003","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Nutman","year":"2003","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(03)00108-9","article-title":"PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease","volume":"3","author":"Coutre","year":"2003","journal-title":"Cancer Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood-2005-08-3153","article-title":"The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)\/chronic eosinophilic leukemia (CEL)-like disease","volume":"107","author":"Yamada","year":"2006","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.172.5.1425","article-title":"Eosinophilia in transgenic mice expressing interleukin 5","volume":"172","author":"Sanderson","year":"1990","journal-title":"J Exp Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000312134","article-title":"FIP1L1\/PDGFR\u03b1-Associated Systemic Mastocytosis","volume":"152","author":"Cancelas","year":"2010","journal-title":"International Archives of Allergy and Immunology"},{"key":"7","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1182\/blood-2003-07-2479","article-title":"The EOL-1 cell line as anmodel for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia","volume":"103","author":"Cools","year":"2004","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"10968","DOI":"10.1074\/jbc.275.15.10968","article-title":"ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis","volume":"275","author":"Bertics","year":"2000","journal-title":"J Biol Chem"},{"key":"9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2183\/pjab.87.463","article-title":"Interleukin-5 and IL-5 receptor in health and diseases","volume":"87","author":"Takatsu","year":"2011","journal-title":"Proceedings of the Japan Academy, Series B"},{"key":"10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cellimm.2004.04.005","article-title":"Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene","volume":"228","author":"Takatsu","year":"2004","journal-title":"Cell Immunol"},{"key":"11","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1073\/pnas.0601192103","article-title":"Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent","volume":"103","author":"Cools","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cytogfr.2014.03.003","article-title":"PDGF receptor signaling networks in normal and cancer cells","volume":"25","author":"Essaghir","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2008.00758.x","article-title":"Multiple roles of Lyn kinase in myeloid cell signaling and function","volume":"228","author":"Lowell","year":"2009","journal-title":"Immunol Rev"},{"key":"14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.exphem.2008.04.017","article-title":"Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFR\u03b1.","volume":"36","author":"Superti-Furga","year":"2008","journal-title":"Experimental Hematology"},{"key":"15","doi-asserted-by":"crossref","first-page":"e34912","DOI":"10.1371\/journal.pone.0034912","article-title":"Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL.","volume":"7","author":"Duan","year":"2012","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"crossref","first-page":"e20932","DOI":"10.1371\/journal.pone.0020932","article-title":"Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase\/Akt pathway","volume":"6","author":"Wong","year":"2011","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Tefferi","year":"2004","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood.V91.10.3734","article-title":"Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway","volume":"91","author":"Miura","year":"1998","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood-2007-11-126268","article-title":"FIP1L1\/PDGFRalpha synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia\/hypereosinophilic syndrome","volume":"112","author":"Rothenberg","year":"2008","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2395-3977.151490","article-title":"Phosphoinositide 3-kinase\/Akt Pathway Mediates Fip1-like1-platelet-derived Growth Factor Receptor \u03b1-induced Cell Infiltration and Activation: Possible Molecular Mechanism for the Malignant Phenotype of Chronic Eosinophilic Leukemia","volume":"1","author":"Duan","year":"2015","journal-title":"Cancer Transl Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4939-1016-8_26","article-title":"Murine models of eosinophilic leukemia: a model of FIP1L1-PDGFRalpha initiated chronic eosinophilic leukemia\/systemic mastocytosis","volume":"1178","author":"Rothenberg","year":"2014","journal-title":"Methods Mol Biol"},{"key":"22","first-page":"516","article-title":"Chemoattractant-Induced Signaling via the Ras-ERK and PI3K-Akt Networks, along with Leukotriene C4 Release, Is Dependent on the Tyrosine Kinase Lyn in IL-5- and IL-3-Primed Human Blood Eosinophils","volume":"186","author":"Bertics","year":"2010","journal-title":"J Immunol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.168.4.1978","article-title":"Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation","volume":"168","author":"Alam","year":"2002","journal-title":"J Immunol"},{"key":"24","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1074\/jbc.M807489200","article-title":"FIP1L1-PDGFR Imposes Eosinophil Lineage Commitment on Hematopoietic Stem\/Progenitor Cells","volume":"284","author":"Kanakura","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"25","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1158\/0008-5472.CAN-06-4183","article-title":"Molecular Mechanisms Underlying FIP1L1-PDGFRA-Mediated Myeloproliferation","volume":"67","author":"Coffer","year":"2007","journal-title":"Cancer Research"},{"key":"26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2007.12.063","article-title":"Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha","volume":"366","author":"Hirasawa","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08977190600581327","article-title":"The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling","volume":"24","author":"Harder","year":"2006","journal-title":"Growth Factors"},{"key":"28","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1073\/pnas.90.16.7696","article-title":"The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells","volume":"90","author":"Courtneidge","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.18632\/oncotarget.1787","article-title":"HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation","volume":"5","author":"Soroceanu","year":"2014","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tins.2009.07.007","article-title":"Critical role of nociceptor plasticity in chronic pain","volume":"32","author":"Levine","year":"2009","journal-title":"Trends Neurosci"},{"key":"31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1165\/rcmb.2007-0154OC","article-title":"Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways","volume":"38","author":"Bochner","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2013.05.025","article-title":"Bafetinib inhibits functional responses of human eosinophils","volume":"715","author":"Cortijo","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2013-01-473405","article-title":"Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice","volume":"122","author":"Rosenberg","year":"2013","journal-title":"Blood"},{"key":"34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.2011.08663.x","article-title":"Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis","volume":"153","author":"Yokote","year":"2011","journal-title":"Br J Haematol"},{"key":"35","doi-asserted-by":"crossref","first-page":"e84746","DOI":"10.1371\/journal.pone.0084746","article-title":"Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR\/p70S6K\/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera","volume":"9","author":"Miura","year":"2014","journal-title":"PLoS One"},{"key":"36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1165\/rcmb.2005-0076OC","article-title":"Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase","volume":"33","author":"Zhu","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"20746","DOI":"10.1074\/jbc.M211402200","article-title":"A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation","volume":"278","author":"Baird","year":"2003","journal-title":"J Biol Chem"},{"key":"38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Takatsu","year":"2009","journal-title":"Int Immunol"},{"key":"39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1074\/mcp.M114.044404","article-title":"Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity","volume":"14","author":"Moran","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"40","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/bcj.2013.41","article-title":"Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: inhibition of Jak2 inactivates Lyn kinase","volume":"3","author":"Arlinghaus","year":"2013","journal-title":"Blood Cancer J"},{"key":"41","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2009.7","article-title":"Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients","volume":"28","author":"Arlinghaus","year":"2009","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18632\/genesandcancer.49","article-title":"HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells","volume":"6","author":"Arlinghaus","year":"2015","journal-title":"Genes Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/1947601910372232","article-title":"Destabilization of Bcr-Abl\/Jak2 Network by a Jak2\/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML).","volume":"1","author":"Arlinghaus","year":"2010","journal-title":"Genes Cancer"},{"key":"44","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.18632\/oncotarget.2090","article-title":"Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRalpha-expressing cells","volume":"5","author":"Pan","year":"2014","journal-title":"Oncotarget"},{"key":"45","first-page":"546","article-title":"Successful treatment with low-dose dasatinib in a patient with chronic eosinophilic leukemia intolerant to imatinib. [Article in Japanese].","volume":"52","author":"Harada","year":"2011","journal-title":"Rinsho Ketsueki"},{"key":"46","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2147\/DDDT.S80207","article-title":"The role of dasatinib in the management of chronic myeloid leukemia","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1756-8722-4-32","article-title":"Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line","volume":"4","author":"Ohyashiki","year":"2011","journal-title":"J Hematol Oncol"},{"key":"48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Wolff","year":"1975","journal-title":"Medicine (Baltimore)."},{"key":"49","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1182\/blood-2003-07-2479","article-title":"The EOL-1 cell line as anmodel for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia","volume":"103","author":"Gilliland","year":"2004","journal-title":"Blood"},{"key":"50","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"Boyum","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"51","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1073\/pnas.80.10.2931","article-title":"Demonstration of permanent factor-dependent multipotential (erythroid\/neutrophil\/basophil) hematopoietic progenitor cell lines","volume":"80","author":"Eckner","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/BF02850216","article-title":"Effect of interleukin-5 receptor-alpha short hairpin RNA-expressing vector on bone marrow eosinophilopoiesis in asthmatic mice","volume":"23","author":"Yin","year":"2006","journal-title":"Adv Ther"},{"key":"53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Riccardi","year":"1991","journal-title":"J Immunol Methods"},{"key":"54","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1128\/MCB.24.17.7435-7443.2004","article-title":"Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance","volume":"24","author":"Rui","year":"2004","journal-title":"Mol Cell Biol"},{"key":"55","first-page":"141","article-title":"Serum MBP immunoreactivity and immunoglobulin level as markers of tumour type","volume":"2","author":"Thomas","year":"1984","journal-title":"J Neurooncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:28:47Z","timestamp":1594830527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":55,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017,9,12]]}},"alternative-id":["11401","29029406"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11401","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,19]]}}}